What do we really know about the treatment of delirium with antipsychotics? Ten key issues for delirium pharmacotherapy

American Journal of Geriatric Psychiatry

Volumn 21, Issue 12, 2013, Pages 1223-1238

  Meagher, David J ^a,b   McLoughlin, Lisa ^a,b   Leonard, Maeve ^a,b   Hannon, Noel ^a,b   Dunne, Colum ^b   O'Regan, Niamh ^c  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Antipsychotics; Delirium; Pharmacotherapy; Treatment

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; HALOPERIDOL; LORAZEPAM; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; PEROSPIRONE; PLACEBO; QUETIAPINE; RISPERIDONE;

BEHAVIOR DISORDER; CHECKLIST; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; COMPARATIVE STUDY; CONFUSION ASSESSMENT METHOD; DELIRIUM; DELIRIUM RATING SCALE; DEMENTIA; DRUG EFFICACY; DRUG WITHDRAWAL; DSM-III-R; DSM-IV; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPOTENSION; INTENSIVE CARE DELIRIUM SCREENING CHECKLIST; LOW DRUG DOSE; MEDLINE; MEMORIAL DELIRIUM ASSESSMENT SCHEDULE; MINI MENTAL STATE EXAMINATION; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PARKINSONISM; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; REVISED DELIRIUM RATING SCALE; RISK FACTOR; SEDATION; SIDE EFFECT; SLEEP DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIPSYCHOTICS; DELIRIUM; PHARMACOTHERAPY; TREATMENT;

ANTIPSYCHOTIC AGENTS; DELIRIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; HUMANS; RISPERIDONE;

EID: 84888645458     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2012.09.008     Document Type: Article

References (109)

1. Siddiqi N, House AO, Holmes JD: Occurrence and outcome of delirium in medical inpatients: a systematic literature review. Age Ageing 2006;35:350-364
2. Meagher D: More attention, less confusion: time to lessen the burden of delirium. Int Rev Psychiatry 2009;21:1-3
3. Meagher DJ: Impact of an educational workshop upon attitudes towards pharmacotherapy for delirium. Int Psychogeriatr 2010;22:938-946
4. National Institute for Health and Clinical Excellence: Delirium: Diagnosis, Prevention and Management. (Clinical guideline 103). 2010. Available at: www.nice.org.uk/CG103. Accessed February 2, 2013
5. Hill EH, Blumenfield M, Orlowski B: A modification of the Trzepacz Delirium Rating ScaleeRevised-98 for use on the Palm Pilot, and a presentation of data of symptom monitoring using haloperidol, olanzapine, and risperidone in the treatment of delirious hospitalized patients. Psychosomatics 2002;43:2
6. Nakamura J, Uchimura N, Yamada S, et al: Effects of mianserin hydrochloride on delirium: comparison with the effects of oxypertine and haloperidol. Nihon Shinkei Seishin Yakurigaku Zasshi 1994;14:269-277
7. Nakamura J, Uchimura N, Yamada S, et al: Does plasma free-3-methoxy-4- hydroxyphenyl (ethylene) glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. Int Clin Psychopharmacol 1997;12:147-152
8. Maneeton B, Maneeton N, Srisurapanont M: An open-label study of quetiapine for delirium. J Med Assoc Thai 2007;90:2158-2163
9. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996;17:1-12
10. Olivo SA, Macedo LG, Gadotti IC, et al: Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 2008;88:156-175
11. Woods SW: Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667
12. Trzepacz PT, Meagher D, Leonard M: Delirium, in Textbook of Psychosomatic Medicine. Edited by Levenson J. Washington, DC, American Psychiatric Press Inc., 2010, pp 70-114
13. Breitbart W, Marotta R, Platt MM, et al: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231-237
14. Van Eijk MM, Roes KC, Honing ML, et al: Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010;376:1829-1837
15. Hua H, Wei D, Hui Y, et al: Olanzapine and haloperidol for senile delirium: a randomised controlled observation. Chin J Clin Rehabil 2006;10:188-190
16. Tahir TA, Eeles E, Karapareddy V, et al: A randomised controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010;69:485-490
17. Devlin JW, Roberts RJ, Fong JJ, et al: Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010;38:419-427
18. Kim KY, Bader GM, Kotlyar V, et al: Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003;16:29-31
19. Skrobik YK, Bergeron N, Dumont M, et al: Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004;30:444-449
20. Kim JY, Jung IK, Han C, et al: Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 2005;59:183-188
21. Takeuchi T, Furuta K, Hirasawa T, et al: Perospirone in the treatment of patients with delirium. Psychiatry Clin Neurosci 2007;61:67-70
22. Kim SW, Yoo JA, Lee SY, et al: Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharmacol 2010;25:298-302
23. Grover S, Kumar V, Chakrabarti S: Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res 2011;71:277-281
24. Boettger S, Breitbart W: An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients. Palliat Support Care 2011;9:351-357
25. Pandharipande P, Shintani A, Peterson J, et al: Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21-26
26. Gaudreau JD, Gagnon P, Harel F, et al: Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23:6712-6718
27. Horikawa N, Yamazaki T, Miyamoto K, et al: Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003;25:289-292
28. Parellada E, Baeza I, De Pablo J, et al: Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004;65:348-353
29. Dorsey ER, Rabbani A, Gallagher SA, et al: Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med 2010;170:96-103
30. American Psychiatric Association: Practice guidelines for the treatment of patients with delirium. Am J Psychiatry 1999;156(suppl):1-20
31. British Geriatrics Society & Royal College of Physicians: Guidelines for the Prevention, Diagnosis, and Management of Delirium in Older People. London, Royal College of Physicians of London, 2006
32. Hogan D, Gage L, Bruto V: National guidelines for senior mental health: the assessment and treatment of delirium. Can J Geriatr 2006;9(suppl 2):42-51
33. Hally O, Cooney C: Delirium in the hospitalized elderly: an audit of NCHD prescribing practice. Ir J Psychol Med 2005;22:133-136
34. Tropea J, Slee J, Holmes AC, et al: Use of antipsychotic medications for the management of delirium: an audit of current practice in the acute care setting. Int Psychogeriatr 2009;21:172-179
35. Hui D, Reddy A, Palla S, et al: Neuroleptic prescription pattern for delirium in patients with advanced cancer. J Palliat Care 2011;27:141-147
36. Briskman I, Dubinski R, Barak Y: Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes. Int Psychogeriatr 2010;22:328-331
37. Ely EW, Stephens RK, Jackson JC, et al: Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004;32:106-112
38. Patel RP, Gambrell M, Speroff T, et al: Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 2009;37:825-832
39. Salluh JI, Dal-Pizzol F, Mello PV, et al: Delirium recognition and sedation practices in critically ill patients: a survey on the attitudes of 1015 Brazilian critical care physicians. J Crit Care 2009;24:556-562
40. MacSweeney R, Barber V, Page V, et al: A national survey of the management of delirium in UK intensive care units. QJM 2010;103:243-251
41. Devlin JW, Bhat S, Roberts RJ, et al: Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight states. Ann Pharmacother 2011;45:1217-1229
42. Straker DA, Shapiro PA, Muskin PR: Aripiprazole in the treatment of delirium. Psychosomatics 2006;47:385-391
43. Lee KU, Won WY, Lee HK, et al: Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol 2005;20:311-314
44. Young C, Lujan E: Intravenous ziprasidone for treatment of delirium in the intensive care unit. Aesthesiology 2004;101:794-795
45. Leso L, Schwartz TL: Ziprasidone treatment of delirium. Psychosomatics 2002;43:61-62
46. Meagher D, Adamis D, Trzepacz P, et al: Features of subsyndromal and persistent delirium. Br J Psychiatry 2012;200:37-44
47. Leonard M, Adamis D, Jordan C, et al: A longitudinal study of delirium phenomenology supports widespread neural dysfunction. Am J Geriatr Psychiatry 2013;21
48. Sasaki Y, Matsuyama T, Inoue S, et al: A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003;64:1316-1321
49. Devlin JW, Skrobik Y, Riker RR, et al: Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a doubleblind, randomized, placebo-controlled study. Crit Care 2011;15:R215
50. Meagher DJ, Moran M, Raju B, et al: Phenomenology of delirium. Assessment of 100 adult cases using standardised measures. Br J Psychiatry 2007;190:135-141
51. Franco JG, Trzepacz PT, Mejia MA, et al: Factor analysis of the Colombian translation of the Delirium Rating Scale (DRS), Revised-98. Psychosomatics 2009;50:255-262
52. Jabbar F, Leonard M, Meehan K, et al: Neuropsychiatric and cognitive profile of patients with DSM-IV delirium referred to an old age psychiatry consultation-liaison service. Int Psychogeriatr 2011;23:1167-1174
53. Mattoo SK, Grover S, Chakravarty G, et al: Symptom profile and etiology of delirium in a referral population in northern India: factor analysis of the DRS-R98. J Neuropsychiatry Clin Neurosci 2012;24:95-101
54. Van Der Cammen T J M, Tiemeier H, Engelhart MJ, et al: Abnormal neurotransmitter metabolite levels in Alzheimer patients with a delirium. Int J Geriatr Psychiatry 2006;21:838-843
55. Thomas C, Hestermann U, Kopitz J, et al: Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium. BMC Neurosci 2008;9:86
56. Meagher D, O'Hanlon D, O'Mahony E, et al: The use of environmental strategies and psychotropic medications in the management of delirium. Br J Psychiatry 1996;168:512-515
57. Meagher D, Leonard M, Donnelly S, et al: A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis. J Psychosomatic Res 2011;71:395-403
58. Gupta N, De Jonghe J, Schieveld J, et al: Delirium phenomenology: what can we learn from the symptoms of delirium? J Psychosom Res 2008;65:215-222
59. Maclullich AM, Ferguson KJ, Miller T, et al: Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 2008;65:229-238
60. Kazmierski J, Kowman M, Banach M, et al: The use of DSM-IV and ICD-10 criteria and diagnostic scales for delirium among cardiac surgery patients: results from the IPDACS study. J Neuropsychiatry Clin Neurosci 2010;22:426-432
61. Cole MG, Dendukuri N, McCusker J, et al: An empirical study of different diagnostic criteria for delirium among elderly medical inpatients. J Neuropsychiatry Clin Neurosci 2003;15:200-207
62. Laurila JV, Pitkala KH, Strandberg TE, et al: The impact of different diagnostic criteria on prevalence rates for delirium. Dement Geriatr Cogn Disord 2003;16:156-162
63. Trzepacz PT, Maldonado JR, Kean J, et al: The Delirium Rating ScaleeRevised-98 (DRS-R98). Administration Manual. A Guide to Increase Understanding of How to Solicit Delirium Symptoms to Administer the DRS-R98. Indianapolis, 2009
64. Trzepacz PT, Baker RW, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988;23:89-97
65. Trzepacz PT, Mittal D, Torres R, et al: Validation of the Delirium Rating ScaleeRevised-98: comparison to the Delirium Rating Scale and Cognitive Test for Delirium. J Neuropsychiatry Clin Neurosci 2001;13:229-242
66. Breitbart W, Rosenfeld B, Roth A, et al: The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997;13:128-137
67. Guy W: ECDEU Assessment Manual For Psychopharmacology (rev) 1976. Rockville, MD, U. S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976
68. McCusker J, Cole MG, Dendukuri N, et al: The delirium index, a measure of the severity of delirium: new findings on reliability, validity, and responsiveness. J Am Geriatr Soc 2004;52:1744-1749
69. Bergeron N, Dubois MJ, Dumont M, et al: Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001;27:859-864
70. Cole MG, McCusker J, Ciampi A, et al: The 6- and 12-month outcomes of older medical inpatients who recover from subsyndromal delirium. J Am Geriatr Soc 2008;56:2093-2099
71. Cole MG, McCusker J, Voyer P, et al: Subsyndromal delirium in older long-term care residents: incidence, risk factors, and outcomes. J Am Geriatr Soc 2011;59:1829-1836
72. Skrobik Y, Ahern S, Leblanc M, et al: Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg 2010;111:451-463
73. Hakim SM, Othman AI, Naoum DO: Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. Anesthesiology 2012;116:987-997
74. MacLullich A M J, Beaglehole A, Hall RJ, et al: Delirium and longterm cognitive impairment. Inter Rev Psychiatry 2009;21:30-42
75. Rudberg MA, Pompei P, Foreman MD, et al: The natural history of delirium in older hospitalized patients: a syndrome of heterogeneity. Age Ageing 1997;26:169-174
76. Adamis D, Treloar A, Martin FC, et al: APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients. Int J Geriatr Psychiatry 2007;22:688-694
77. Van Den Boogaard M, Pickkers P, Van Der Hoeven H, et al: Implementation of a delirium assessment tool in the ICU can influence haloperidol use. Crit Care 2009;13:R131
78. González M, Martínez G, Calderón J, et al: Impact of delirium on short-term mortality in elderly inpatients: a prospective cohort study. Psychosomatics 2009;50:234-238
79. Heymann A, Radtke F, Schiemann A, et al: Delayed treatment of delirium increases mortality rate in intensive care unit patients. J Int Med Res 2010;38:1584-1595
80. Kalisvaart KJ, De Jonghe J F M, Bogaards MJ, et al: Haloperidol prophylaxis for elderly hip surgery patients at risk for delirium: a randomized, placebo-controlled study. J Am Geriatr Soc 2005;53:1658-1666
81. Larsen KA, Kelly SE, Stern TA, et al: Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics 2010;51:409-418
82. Prakanrattana U, Prapaitrakool S: Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007;35:714-719
83. Wang W, Li HL, Wang DX, et al: Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial. Crit Care Med 2012;40:731-739
84. Alexopoulos GS, Streim J, Carpenter D, et al: Using antipsychotic agents in older patients. J Clin Psychiatry 2004;65(suppl 2):5-99
85. Meagher D: Motor subtypes of delirium: past, present and future. Int Rev Psychiatry 2009;21:59-73
86. Platt MM, Breitbart W, Smith M, et al: Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994;6:66-67
87. Liu CY, Juang YY, Liang HY, et al: Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004;19:165-168
88. Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002;43:175-182
89. Boettger S, Breitbart W, Passik S: Haloperidol and risperidone in the treatment of delirium and its subtypes. Eur J Psychiatry 2011;25:59-67
90. Meagher D, Leonard M: The active management of delirium: improving detection and treatment. APT 2008;14:292-301
91. Meagher DJ, Moran M, Raju B, et al: A new data-based motor subtype schema for delirium. J Neuropsychiatry Clin Neurosci 2008;20:185-193
92. Sternberg SA, Wolfson C, Baumgarten M: Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging. J Am Geriatr Soc 2000;48:1430-1434
93. Sampson EL, Blanchard MR, Jones L, et al: Dementia in the acute hospital: prospective cohort study of prevalence and mortality. Br J Psychiatry 2009;195:61-66
94. Mittal D, Jimerson NA, Neely EP, et al: Risperidone in the treatment of delirium: results from a prospective open-label trial. J Clin Psychiatry 2004;65:662-667
95. Han CS, Kim YK: Adouble-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004;45:297-301
96. Kim KS, Pae CU, Chae JH, et al: An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 2001;55:515-519
97. Pae CU, Lee SJ, Lee CU, et al: A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol 2004;19:125-127
98. Toda H, Kusumi I, Sasaki Y, et al: Relationship between plasma concentration levels of risperidone and clinical effects in the treatment of delirium. Int Clin Psychopharmacol 2005;2:331-333
99. Omura K, Amano N: Clinical experience of quetiapine in 24 elderly patients with delirium. Psychogeriatrics 2003;3:69-72
100. Boettger S, Passik S, Breitbart W: Treatment characteristics of delirium superimposed on dementia. Int Psychogeriatr 2011;23:1671-1676
101. Marcantonio ER, Flacker JM, Wright RJ, et al: Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001;49:516-522
102. Pitkälä KH, Laurila JV, Strandberg TE, et al: Multicomponent geriatric intervention for elderly inpatients with delirium: a randomized, controlled trial. J Gerontol A Biol Sci Med Sci 2006;61:176-181
103. Ray WA, Chung CP, Murray KT, et al: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009;360:225-235
104. Mittal V, Kurup L, Williamson D, et al: Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence. Am J Alzheimers Dis Other Demen 2011;26:10-28
105. Elie M, Boss K, Cole MG, et al: A retrospective, exploratory, secondary analysis of the association between antipsychotic use and mortality in elderly patients with delirium. Int Psychogeriatr 2009;21:588-592
106. Meyer-Massetti C, Cheng CM, Sharpe BA, et al: The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med 2010;5:E8-16
107. Alici Y, Breitbart W, Rueda-Lara M: Short-term use of atypical antipsychotics in the medically ill: an assessment of adverse metabolic and cardiac effects. Academy of Psychosomatic Medicine Conference Proceedings 2007;45-46
108. Chiu CC, Chen KP, Liu HC, et al: The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients. J Clin Psychopharmacol 2006;26:504-507
109. Seitz DP, Gill SS: Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature. Psychosomatics 2009;50:8-15